UnitedHealth Group Incorporated $UNH Stake Trimmed by State of Alaska Department of Revenue

State of Alaska Department of Revenue lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% in the third quarter, HoldingsChannel.com reports. The firm owned 103,794 shares of the healthcare conglomerate’s stock after selling 3,952 shares during the quarter. State of Alaska Department of Revenue’s holdings in UnitedHealth Group were worth $38,100,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Synergy Financial Group LTD lifted its stake in UnitedHealth Group by 3.1% in the second quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock valued at $369,000 after acquiring an additional 27 shares during the last quarter. LFG Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 3.3% during the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock worth $355,000 after purchasing an additional 27 shares during the last quarter. Ares Financial Consulting LLC increased its stake in shares of UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after purchasing an additional 28 shares during the last quarter. Hudock Inc. raised its holdings in shares of UnitedHealth Group by 1.0% during the 2nd quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock valued at $1,182,000 after purchasing an additional 28 shares in the last quarter. Finally, Rockland Trust Co. lifted its stake in shares of UnitedHealth Group by 1.1% in the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock valued at $1,076,000 after purchasing an additional 29 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock traded up $14.91 during mid-day trading on Thursday, reaching $410.53. 5,614,979 shares of the stock traded hands, compared to its average volume of 7,369,734. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business has a 50-day moving average of $387.10 and a two-hundred day moving average of $383.47. The firm has a market capitalization of $368.49 billion, a PE ratio of 23.43, a P/E/G ratio of 1.41 and a beta of 0.60. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the firm earned $2.59 EPS. The firm’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 20.00 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were issued a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s payout ratio is 59.72%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings beat and raised guidance: UnitedHealth reported third-quarter revenue of $112.7 billion and adjusted EPS of $4.69, exceeding consensus estimates. Management raised its 2026 adjusted EPS outlook to at least $20.50, above the prior range and analyst expectations. UnitedHealth Group gains after Q3 beat and higher 2026 outlook
• Positive Sentiment: Margin recovery is improving: The medical care ratio improved to 88.4%, while better cost management, pricing discipline and benefit changes supported profitability. Goldman Sachs said Medicare Advantage margins are recovering faster than expected, and UnitedHealth described 2026 as a potential bottom for Medicaid margins. Goldman Sachs report on UNH earnings and margin recovery
• Positive Sentiment: 2027 growth prospects attract bullish analyst views: Management highlighted a potential return to stronger growth, including 13%–16% long-term earnings growth, special-needs Medicare plans, expanded coverage and AI tools that reduce administrative work. Goldman Sachs raised its price target to $506, while Piper Sandler maintained an overweight rating with a $504 target. Can UNH’s focus on special needs plans strengthen Medicare growth?
• Neutral Sentiment: Analyst views remain divided: Piper Sandler and Goldman Sachs see substantial upside, but TD Cowen reaffirmed a hold rating with a $402 target. Barclays and Robert W. Baird also reduced their targets, reflecting uncertainty about the pace of recovery.
• Negative Sentiment: Growth risks remain: Revenue was essentially flat year over year, membership has declined, and investors continue to question the company’s growth path. Commercial medical costs and Medicaid pressure could delay broader margin recovery, leaving some analysts concerned that the recent earnings positives are already reflected in the valuation. UnitedHealth beats on earnings, but investors question growth path

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. DA Davidson set a $512.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 21st. The Goldman Sachs Group boosted their price target on UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Jefferies Financial Group increased their price objective on UnitedHealth Group from $401.00 to $490.00 and gave the company a “buy” rating in a report on Friday, July 17th. Finally, Piper Sandler raised their price objective on UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a research note on Wednesday. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $461.48.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.